Exosomes: A Source for New and Old Biomarkers in Cancer
Clinical oncology needs reliable tumor biomarkers to allow a follow-up of tumor patients who do not necessarily need invasive approaches. To date, the existing biomarkers are not sufficiently reliable, and many of them have generated more problems than facilitating the commitment of clinical oncolog...
Main Authors: | Mariantonia Logozzi, Davide Mizzoni, Rossella Di Raimo, Stefano Fais |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2566 |
Similar Items
-
The Importance of Detecting, Quantifying, and Characterizing Exosomes as a New Diagnostic/Prognostic Approach for Tumor Patients
by: Mariantonia Logozzi, et al.
Published: (2023-05-01) -
Microenvironmental pH and Exosome Levels Interplay in Human Cancer Cell Lines of Different Histotypes
by: Mariantonia Logozzi, et al.
Published: (2018-10-01) -
Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers’ Performance
by: Stefano Salciccia, et al.
Published: (2023-07-01) -
Editorial: Exosomal biomarkers: Roles in diagnostics and therapeutics
by: Dwijendra K. Gupta
Published: (2023-01-01) -
Oral Treatment with Plant-Derived Exosomes Restores Redox Balance in H<sub>2</sub>O<sub>2</sub>-Treated Mice
by: Rossella Di Raimo, et al.
Published: (2023-05-01)